IP Library Granted Patent US 10,620,192
Granted Patent B2
US 10,620,192 · App. 15/217,360 · Granted Apr 14, 2020

Modular point-of-care devices, systems, and uses thereof

Inventors: Tammy Burd (Palo Alto, CA); Ian Gibbons (Newark, CA); Elizabeth A. Holmes (Palo Alto, CA); Gary Frenzel (Palo Alto, MD); Anthony Joseph Nugent (Dublin, CA)
Assignee: Theranos IP Company, LLC
G01N33/5304A61B5/15A61B5/151A61B5/150755B01J19/0046B01L3/0262B01L3/5025B01L3/527B01L7/52B01L9/543G01N1/38G01N33/5302G01N33/54326G01N33/54366G01N33/54386G01N33/56966G01N33/57484G01N33/6803G01N33/94G01N35/00732G01N35/00871G01N35/028G01N35/10G01N35/1065G01N35/1074G16H10/40A61B10/007A61B10/0038A61B10/0045A61B10/0051A61B10/0058A61B10/02A61B2010/0074A61B2010/0077B01J2219/005B01J2219/00283B01J2219/00292B01J2219/00315B01J2219/00369B01J2219/00371B01J2219/00385B01J2219/00466B01J2219/00495B01J2219/00693B01J2219/00702B01L3/021B01L7/5255B01L2200/04B01L2200/0689B01L2200/141B01L2200/148B01L2300/0654B01L2300/0829B01L2300/1805B01L2400/043G01N2035/0097G01N2035/00237G01N2035/00851G01N2035/00881G01N2035/1032G01N2035/1034G01N2035/1048G01N2333/475G01N2333/4737G01N2333/71G01N2333/912G01N2333/9129G01N2333/91205G01N2800/26G01N2800/60Y10T29/49826Y10T436/25375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,620,192
App. No.
15/217,360
Granted
Apr 14, 2020
Kind
B2
Abstract

The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.

Claims (34)

1. A method of on-demand assembly of a cartridge for automated detection of an analyte in a bodily fluid sample, the method comprising:

(i) placing, according to the analyte to be detected, an array of addressable assay units, wherein an individual assay unit of the array of the addressable assay units is configured to run a chemical reaction that detects the analyte of interest, into a housing of the cartridge;

(ii) placing, according to the analyte to be detected, an array of reagent units, wherein an individual reagent unit of the array of the reagent units is calibrated with reference to the individual assay unit, into the housing of the cartridge; and

(iii) securing the array of the addressable assay units and the array of the addressable reagent units within the housing of the cartridge;

wherein the array of the addressable assay units and the array of the addressable reagent units are arranged in a two-dimensional pattern along with at least one pipette tip and at least one touch-off pad.

2. The method of claim 1 further comprising selecting an analyte to be detected.

3. The method of claim 1 further comprising sealing the cartridge.

4. The method of claim 1 further comprising labeling the cartridge with a readable label indicating the analyte to be detected.

5. The method of claim 4 , wherein the readable label is a bar code or RFID.

6. The method of claim 1 , wherein the individual assay unit comprises a reaction site having thereon an immobilized binding reagent that is configured to yield a detectable optical signal indicative of the presence of the analyte in the bodily fluid sample.

7. The method of claim 6 , wherein the binding reagent includes one of an antibody and an epitope.

8. The method of claim 6 , wherein the reaction site comprises an immunoassay reaction site.

9. The method of claim 1 , wherein the individual reagent unit is configured to contain a cartridge reagent for running a chemical reaction for detecting the analyte.

10. The method of claim 9 , wherein the cartridge reagent includes one of a conjugate reagent, a wash buffer, a wash solution, a detergent, a polymer, a chelating agent, an albumin-binding reagent, an anticoagulant, an enzyme substrate, a sample diluent, and a detector conjugate.

11. The method of claim 9 , wherein the cartridge reagent comprises a red-cell agglutinating agent.

12. The method of claim 9 , wherein the cartridge reagent comprises alkaline phosphatase.

13. The method of claim 9 , wherein the reagent units is sized to contain between about 20 to about 200 microliters of liquid.

14. A method of on-demand assembly of a cartridge for automated detection of an analyte in a bodily fluid sample, the method comprising:

(i) placing, according to the analyte to be detected, an array of addressable assay units, wherein an individual assay unit of the array of the addressable assay units is configured to run a chemical reaction that detects the analyte of interest, into a housing of the cartridge;

(ii) placing, according to the analyte to be detected, an array of reagent units, wherein an individual reagent unit of the array of the reagent units is calibrated with reference to the individual assay unit, into the housing of the cartridge; and

(iii) securing the array of the addressable assay units and the array of the addressable reagent units within the housing of the cartridge;

wherein the array of the addressable assay units and the array of the addressable reagent units-are arranged in a two-dimensional pattern along with at least one pipette tip and at least one touch-off pad;

wherein the individual reagent unit is configured to contain a cartridge reagent for running a chemical reaction for detecting the analyte and wherein the cartridge reagent comprises a magnetic reagent.

15. The method of claim 14 , wherein the magnetic reagent comprises magnetic bead particles.

16. The method of claim 15 , wherein the magnetic reagent comprises free binding molecules.

17. The method of claim 14 , wherein the magnetic reagent comprises magnetic bead particles coated with an antibody.

18. The method of claim 15 , wherein the magnetic bead particles are each between about 1 to about 1.3 micrometers in size.

19. A method of on-demand assembly of a cartridge for automated detection of an analyte in a bodily fluid sample, the method comprising:

(i) placing, according to the analyte to be detected, an array of addressable assay units, wherein an individual assay unit of the array of the addressable assay units is configured to run a chemical reaction that detects the analyte of interest, into a housing of the cartridge;

(ii) placing, according to the analyte to be detected, an array of reagent units, wherein an individual reagent unit of the array of the reagent units is calibrated with reference to the individual assay unit, into the housing of the cartridge; and

(iii) securing the array of the addressable assay units and the array of the addressable reagent units within the housing of the cartridge;

wherein the array of the addressable assay units and the array of the addressable reagent units-are arranged in a two-dimensional pattern along with at least one pipette tip and at least one touch-off pad;

wherein the individual reagent unit is configured to contain a cartridge reagent for running a chemical reaction for detecting the analyte and wherein the cartridge reagent is in lyophilized form.

20. The method of claim 19 , wherein the cartridge reagent comprises a lyophilized magnetizable bead pellet.

Assignments (5)
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045075/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2016
From: BURD, TAMMY; GIBBONS, IAN; HOLMES, ELIZABETH A.; FRENZEL, GARY; NUGENT, ANTHONY J.
To: THERANOS, INC.
Reel/Frame 039501/0234 →
Continuity (4)
Continuation 13326023 · Dec 14, 2011
Continuation 12244723 · Oct 2, 2008
Provisional Application 60997460 · Oct 2, 2007
Related Publication 20170016904A1 · Jan 19, 2017